Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
Abstract
As a part of a randomized clinical trial, the potential of patients’ education and monitoring by ambulatory therapeutists for improving pharmaceutical prevention and treatment effectiveness in Type 2 diabetes mellitus (DM-2) was evaluated. After 12 months, patients’ compliance and lipid level control improved significantly, as well as selfrated health and quality of life.
About the Author
E. A. Palferova
Бутурлиновская ЦРБ Воронежской области; Российская
медицинская академия последипломного образования Росздрава
Russian Federation
Russian Federation
References
1. И.И.Дедов, М.И.Балаболкин, Е.М.Клебанов и др. Сахарный диабет: патогенез, классификация, диагностика и лечение. Пособие для врачей. М 2003: 79–80; 83; 106–109.
2. UKPDS Group. Intensive bloodJglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes// Lancet 1998; 16: 716–30.
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel ???)// JAMA 2001:2486 –2497.
4. American Diabetes Association. Position statement – management of dyslipidemia in adults with diabetes. Diabetes Care// 2002; 25: S74 – S77.
5. Colwell JA. Aspirin therapy in diabetes (Technical Review)// Diabetes Care 1997; 20: 1767 – 1771.
6. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia// Ann Intern Med 2001; 135: 825 – 834.
7. JP Feuer, B Zinman. Комплаенс и эффективность длительной терапии у пациентов с диабетом 2 типа// Медикография, выпуск 62, том 21, № 4, 1999: 36 – 40.
8. Конради А. О., Полуничева Е. В. Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции// Артериальная гипертензия, т 10, № 3, 2004 г.
9. Lip GY, Beevers GD, Doctors, nurses, pharmacists and patients. The rational evaluation and choice in hypertension (REACH) survey of hypertension delivery// Вlood pressure 1997; 6:6 – 11.
10. Терапевтическое обучение больных. Отчет рабочей группы ВОЗ. Мос к ва, 2001г: 1 – 96.
11. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients// J Cardiovasc Pharmacol 2000; 36 (suppl. 3): S23 – S 26. 12. Faragon JJ, Wait NM, Hobson EH. et al. Improving Aspirin Prophylaxis in Primary Care Diabetes Population// Pharmacotherapy 2003; 23 (1): 73 – 79.
12. Ware JE, Sherburne CD, The MOS 36Jitem shortJform health survey (SF 36): Conceptual framework and item selection// Med Care 1993; 30: 473 – 85.
Review
For citations:
Palferova E.A. Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment. Russian Journal of Cardiology. 2008;(1):57-60. (In Russ.)
Views:
461
Email this article 